$NWBO
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
https://t.co/ioKX57D8lt @NWBO @alphavestcap
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
$NWBO #DCVAX
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
$NWBO
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @ATLnsider: Yesterday, the National iInstitute of Health (NIH) National Cancer Institute (NCI) Neuro-Oncology Journal Club discussed $NW…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
$NWBO
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
RT @NIHBrainTumor: At today's Multidisciplinary Neuro-Oncology Journal Club, we discussed a recent Phase 3 trial by Liau et al. @UCLANsgy,…
Phase 3 results for the treatment she is seeking recently were released. It will take too long to be approved. But the UK has a program that allows early access. It's not covered by national insurance. It's a personalized cellular vaccine called #DCVaxL
@JacobPlieth @evaluatevantage $NWBO will come and save Keytruda
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
Excellent! #GBM #BTSM https://t.co/lgVZHJQpQw
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @TimPollheide: $NWBO l
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
$nwbo @alphavestcap https://t.co/t5GiewVGKo . .
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @gcelisdelvalle: $NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @DawnAnnManning: #NWBO 💯
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
$NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
#NWBO 💯
RT @sentimentstock: $NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
$NWBO l
RT @alphavestcap: https://t.co/TfkKa3b6q6 $nwbo @alphavestcap
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @sentimentstock: $NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
$NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
https://t.co/TfkKa3b6q6 $nwbo @alphavestcap
$nwbo "Best Advances of 2022" and Nothing but a litany of major milestones for the last 3 years. $2.50 to $.72? And therein hangs a tale of #CitadelScandal. #nakedshorts estimated to approx entire actual float. $nwbo leads the charge by suing #Citadel etc.
RT @sentimentstock: $NWBO
RT @sentimentstock: $NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @sentimentstock: $NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @sentimentstock: $NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
$nwbo
$NWBO
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
RT @StevenBremMD: Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cel…
Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cell vaccine trial, led by Dr. Linda Liau, as one of the "Best Advances of 2022." #immunotherapy @PennNeurology @PennNSG @PennCancer ht
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…